233 related articles for article (PubMed ID: 22147696)
1. Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16.
Starr AE; Dufour A; Maier J; Overall CM
J Biol Chem; 2012 Feb; 287(8):5848-60. PubMed ID: 22147696
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities.
Starr AE; Bellac CL; Dufour A; Goebeler V; Overall CM
J Biol Chem; 2012 Apr; 287(16):13382-95. PubMed ID: 22367194
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM
Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
McQuibban GA; Butler GS; Gong JH; Bendall L; Power C; Clark-Lewis I; Overall CM
J Biol Chem; 2001 Nov; 276(47):43503-8. PubMed ID: 11571304
[TBL] [Abstract][Full Text] [Related]
7. Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.
Arakelyan A; Kriegova E; Kubistova Z; Mrazek F; Kverka M; du Bois RM; Kolek V; Petrek M
Clin Exp Immunol; 2009 Mar; 155(3):457-65. PubMed ID: 19220835
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
Cox JH; Dean RA; Roberts CR; Overall CM
J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
[TBL] [Abstract][Full Text] [Related]
9. An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.
Rump L; Mattey DL; Kehoe O; Middleton J
Cytokine; 2017 Sep; 97():133-140. PubMed ID: 28648867
[TBL] [Abstract][Full Text] [Related]
10. Moonlighting matrix metalloproteinase substrates: Enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage.
Jobin PG; Solis N; Machado Y; Bell PA; Rai SK; Kwon NH; Kim S; Overall CM; Butler GS
J Biol Chem; 2020 Feb; 295(8):2186-2202. PubMed ID: 31771979
[TBL] [Abstract][Full Text] [Related]
11. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
[TBL] [Abstract][Full Text] [Related]
12. Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness.
Richter R; Bistrian R; Escher S; Forssmann WG; Vakili J; Henschler R; Spodsberg N; Frimpong-Boateng A; Forssmann U
J Immunol; 2005 Aug; 175(3):1599-608. PubMed ID: 16034099
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
Miao Z; Premack BA; Wei Z; Wang Y; Gerard C; Showell H; Howard M; Schall TJ; Berahovich R
J Immunol; 2007 Jun; 178(11):7395-404. PubMed ID: 17513790
[TBL] [Abstract][Full Text] [Related]
14. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
Li Y; Wu J; Zhang P
Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
[TBL] [Abstract][Full Text] [Related]
15. Increase of expression and activation of chemokine CCL15 in chronic renal failure.
Richter R; Forssmann U; Henschler R; Escher S; Frimpong-Boateng A; Forssmann WG
Biochem Biophys Res Commun; 2006 Jul; 345(4):1504-12. PubMed ID: 16737685
[TBL] [Abstract][Full Text] [Related]
16. Structure and Dynamics of Human Chemokine CCL16-Implications for Biological Activity.
Weiergräber OH; Petrović D; Kislat A; Pattky M; Fabig J; Batra-Safferling R; Schulte Am Esch J; Hänel K; Huhn C; Strodel B; Homey B; Willbold D
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358937
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes.
Kim CS; Kang JH; Cho HR; Blankenship TN; Erickson KL; Kawada T; Yu R
Inflamm Res; 2011 Sep; 60(9):889-95. PubMed ID: 21656154
[TBL] [Abstract][Full Text] [Related]
18. Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells.
Kwon SH; Ju SA; Kang JH; Kim CS; Yoo HM; Yu R
Nutr Res Pract; 2008; 2(2):134-7. PubMed ID: 20126378
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.
Dean RA; Cox JH; Bellac CL; Doucet A; Starr AE; Overall CM
Blood; 2008 Oct; 112(8):3455-64. PubMed ID: 18660381
[TBL] [Abstract][Full Text] [Related]
20. [Biological function explore of protein CCL15 in HCC cell lines].
Li YG; Zhang P
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):372-6. PubMed ID: 22971284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
